Motilal Oswal has suggested a BUY recommendation on insurance major Star Health, affirming its robust fundamentals and forecasting a steady improvement in profitability.

Motilal Oswal Financial Services has reiterated a resounding BUY call on Mahindra & Mahindra (M&M), projecting unwavering confidence in the company’s ability to outperform the broader marke

Kotak Institutional Equities has maintained a "BUY" rating on Gateway Distriparks (GRFL), targeting a fair value of Rs 82 against a prevailing market price of Rs 68.

Kotak Institutional Equities has reiterated its bullish stance on Lodha Developers, assigning a "BUY" call with a revised fair value of Rs1,500 per share.

Kotak Institutional Equities has struck a bullish note on Piramal Pharma with its latest research, reiterating a BUY recommendation and projecting a fair value of Rs305 per share against a current

Kotak Institutional Equities has reiterated its bullish stance on Acme Solar Holdings (ACMESOLA), assigning a “BUY” call with an upgraded fair value of Rs350 per share.